Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jacobs

Showing results (241-250 of 1,506) with videos related to

Pageof 151
Sort By:
Der Orthopade|May 14, 2003
[Rehabilitation after flexor tendon surgery]P Hahn, C Jacobs, A Müller-Zimmermann
JAMA Neurology|May 16, 2017
Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-ReplyWillem-Jan R Fokkink, Bart C Jacobs
The Lancet. Neurology|November 18, 2006
Predicting the course of Guillain-Barré syndromePieter A van Doorn, Bart C Jacobs
Human Pathology|July 1, 1996
Apoptotic versus proliferative activities in human benign prostatic hyperplasiaN Kyprianou, H Tu, S C Jacobs
Handbook of Clinical Neurology|January 12, 2026
Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathiesLinda W G Luijten, Bart C Jacobs
Urology|January 11, 2000
Laparoscopic nephrectomy in the markedly obese living renal donorS C Jacobs, E Cho, B J Dunkin, et al.
Surgical Laparoscopy & Endoscopy|June 1, 1991
Laparoscopic pelvic lymphadenectomyJ L Flowers, J Feldman, S C Jacobs
British Medical Journal|December 18, 1976
Prednisone in MOPP chemotherapy for Hodgkin's diseaseC Jacobs, C S Portlock, S A Rosenberg
Carcinogenesis|December 1, 1996
Characterization of a putative p53 binding site in the promoter of the mouse tissue inhibitor of metalloproteinases-3 (TIMP-3) gene: TIMP-3 is not a p53 target geneJ Bian, C Jacobs, Y Wang, et al.
Oncogene|January 30, 1997
Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compoundY Sun, J Bian, Y Wang, et al.
Pageof 151

Showing results (241-250 of 1,506) with videos related to

Sort By:
Pageof 151
Der Orthopade|May 14, 2003
[Rehabilitation after flexor tendon surgery]P Hahn, C Jacobs, A Müller-Zimmermann
JAMA Neurology|May 16, 2017
Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-ReplyWillem-Jan R Fokkink, Bart C Jacobs
The Lancet. Neurology|November 18, 2006
Predicting the course of Guillain-Barré syndromePieter A van Doorn, Bart C Jacobs
Human Pathology|July 1, 1996
Apoptotic versus proliferative activities in human benign prostatic hyperplasiaN Kyprianou, H Tu, S C Jacobs
Handbook of Clinical Neurology|January 12, 2026
Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathiesLinda W G Luijten, Bart C Jacobs
Urology|January 11, 2000
Laparoscopic nephrectomy in the markedly obese living renal donorS C Jacobs, E Cho, B J Dunkin, et al.
Surgical Laparoscopy & Endoscopy|June 1, 1991
Laparoscopic pelvic lymphadenectomyJ L Flowers, J Feldman, S C Jacobs
British Medical Journal|December 18, 1976
Prednisone in MOPP chemotherapy for Hodgkin's diseaseC Jacobs, C S Portlock, S A Rosenberg
Carcinogenesis|December 1, 1996
Characterization of a putative p53 binding site in the promoter of the mouse tissue inhibitor of metalloproteinases-3 (TIMP-3) gene: TIMP-3 is not a p53 target geneJ Bian, C Jacobs, Y Wang, et al.
Oncogene|January 30, 1997
Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compoundY Sun, J Bian, Y Wang, et al.
Pageof 151